# Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/belimumab-may-decrease-flare-rate-and-allow-glucocorticoid-withdrawal-in-lupus/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Valentina Binda,Barbara Trezzi,Nicoletta Del Papa,Lorenzo Beretta,Giulia Frontini,Giulia Porata,Paolo Fabbrini,Maria Rosa Pozzi,Piergiorgio Messa,Renato Alberto Sinico,Gabriella Moroni |
| Citations | 36 |
| DOI | 10.1007/s40620-020-00706-3 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3003622751 |
| PMID | 32002799 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Valentina Binda](https://scholariq.org/researchers/valentina-binda/)

## Paper journal

- [Journal of Nephrology](https://scholariq.org/journals/journal-of-nephrology/)

## Paper primary topic

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Paper topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.